NIH Funding Announcements

Syndicate content
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 14 hours 48 min ago

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Mon, 11/13/2017 - 10:51
Funding Opportunity PA-18-286 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage submission of Exploratory/Developmental Bioengineering Research Grants (EBRG) applications which establish the feasibility of technologies, techniques or methods that: 1) explore a new multidisciplinary approach to a biomedical challenge; 2) are high-risk but have high impact; and 3) develop data that may lead to significant future research. An EBRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research and is appropriate for evaluating unproven approaches for which there is minimal or no preliminary data.
Categories: NIH-Funding

Pathogenesis of Age-Related HIV Neurodegeneration (R01 Clinical Trial Not Allowed)

Mon, 11/13/2017 - 03:09
Funding Opportunity RFA-AG-18-023 from the NIH Guide for Grants and Contracts. NeuroHIV is at an inflection point, with an urgent need to understand the mechanisms that cause and modulate the CNS impairment in the era of antiretroviral therapies.
Categories: NIH-Funding

NIDCD Clinical Trials in Communication Disorders (R01-Clinical Trial Required)

Mon, 11/13/2017 - 02:48
Funding Opportunity PA-18-334 from the NIH Guide for Grants and Contracts. The NIDCD is committed to identifying effective interventions for the diagnosis, prevention, or treatment of communication disorders by supporting welldesigned and wellexecuted clinical trials. This funding opportunity announcement (FOA) supports investigator initiated low risk clinical trials addressing the mission and research interests of NIDCD. Clinical trials must meet ALL the following criteria: meet the budget limits of this FOA, not require FDA oversight, are not intended to formally establish efficacy and have low risks to potentially cause physical or psychological harm. It is advisable that only one clinical trial be proposed in each NIDCD Clinical Trials in Communication Disorders R01 application. High risk clinical trials not meeting all the criteria above are referred companion U01 FOA PAR-18-340, NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders.
Categories: NIH-Funding

NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01-Clinical Trial Required)

Mon, 11/13/2017 - 02:48
Funding Opportunity PAR-18-340 from the NIH Guide for Grants and Contracts. The NIDCD is committed to identifying effective interventions for the treatment or prevention of communication disorders by supporting welldesigned and wellexecuted clinical trials. This funding opportunity announcement (FOA) supports a cooperative agreement between an NIDCD Project Scientist and an investigator to support a clinical trial that meets ANY of the following criteria: requires FDA oversight, has annual direct costs equal to or greater than $500,000, that is intended to formally establish efficacy, or has a higher risk to potentially cause physical or psychological harm. These investigator-initiated clinical trials are perceived to benefit from close interaction, oversight, and guidance resulting from a cooperative agreement. Only one clinical trial may be proposed in each NIDCD Clinical Trials in Communication Disorders U01 application. Low risk clinical trials not meeting any of the criteria above are referred to the companion NIDCD Clinical Trials in Communication Disorders (R01-Clinical Trial Required) PA-18-334
Categories: NIH-Funding

Contraception Research Centers Program (U54)

Thu, 11/09/2017 - 13:45
Funding Opportunity RFA-HD-18-035 from the NIH Guide for Grants and Contracts. The primary purpose of this announcement is to support and facilitate multidisciplinary approaches to the development of new and/or improved contraceptive methods for both men and women through the formation of Contraceptive Research Centers. This FOA also allows the inclusion of behavioral and social science research projects to inform on contraceptive use and non-use of marketed products or products in clinical development. The Centers will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.
Categories: NIH-Funding

Studies of HIV in Digestive Diseases Limited to Gastrointestinal Mucosal Immunology and Liver Diseases (R01- Clinical Trial Optional)

Thu, 11/09/2017 - 12:46
Funding Opportunity RFA-DK-17-038 from the NIH Guide for Grants and Contracts. The goal of this FOA is to support innovative, basic and translational research in two areas, gastrointestinal (GI) mucosal immunology and liver disease. The emphasis for GI mucosal immunology is on elucidation of mechanisms whereby innate and adaptive immunity in the GI tract interacts with HIV infection in the presence or absence of antiretroviral therapy (ART) and contributes to HIV infection, persistence, disruption of GI homeostasis, and pathogenesis. The emphasis for liver disease is on pathophysiologic mechanisms of injury to the liver and the biliary system during HIV infection and epidemiological studies of liver diseases and disorders in HIV patients.
Categories: NIH-Funding

Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) (Clinical Trial Required)

Thu, 11/09/2017 - 12:31
Funding Opportunity RFA-HL-18-027 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds underrepresented in research. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from Institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators.
Categories: NIH-Funding

Notice of Clarification to PAR-15-304 Clinical and Translational Science Award (U54)

Thu, 11/09/2017 - 11:25
Notice NOT-TR-18-006 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Notice of NHLBI Participation in PA-17-225 "Advancing the Science of Geriatric Palliative Care (R01)

Thu, 11/09/2017 - 11:20
Notice NOT-HL-17-558 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Reducing Health Disparities Among Minority and Underserved Children (R21 Clinical Trial Optional)

Wed, 11/08/2017 - 11:35
Funding Opportunity PA-18-169 from the NIH Guide for Grants and Contracts. This initiative encourages research that targets the reduction of health disparities among children. Investing in early childhood development is essential. Specific targeted areas of research include bio-behavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (e.g., physical and family environments) social (e.g., peers), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known health condition and/or disability; and studies that test, evaluate, translate, and disseminate health promotion prevention and interventions conducted in traditional and non -traditional settings
Categories: NIH-Funding

Chronic Condition Self-Management in Children and Adolescents (R21 Clinical Trial Optional)

Wed, 11/08/2017 - 11:33
Funding Opportunity PA-18-168 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage exploratory/developmental research to improve self-management and quality of life in children and adolescents with chronic conditions. Managing a chronic condition is an unremitting responsibility for children and their families. Children with a chronic condition and their families have a long-term responsibility for self-management. This FOA encourages research that takes into consideration various factors that influence self-management such as individual differences, biological and psychological factors, family/caregivers and sociocultural context, family-community dynamics, healthcare system factors, technological advances, and the role of the environment.
Categories: NIH-Funding

Reducing Health Disparities Among Minority and Underserved Children (R01 Clinical Trial Optional)

Wed, 11/08/2017 - 11:31
Funding Opportunity PA-18-152 from the NIH Guide for Grants and Contracts. This initiative encourages research that targets the reduction of health disparities among children. Investing in early childhood development is essential. Specific targeted areas of research include bio-behavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (e.g., physical and family environments) social (e.g., peers), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known health condition and/or disability; and studies that test, evaluate, translate, and disseminate health promotion prevention and interventions conducted in traditional and non -traditional settings.
Categories: NIH-Funding